Diagnostic performance of T(1) and T(2) mapping to detect intramyocardial hemorrhage in reperfused ST-segment elevation myocardial infarction (STEMI) patients

T1和T2映射在检测再灌注ST段抬高型心肌梗死(STEMI)患者心肌内出血方面的诊断性能

阅读:1

Abstract

PURPOSE: To investigate the performance of T(1) and T(2) mapping to detect intramyocardial hemorrhage (IMH) in ST-segment elevation myocardial infarction (STEMI) patients treated by primary percutaneous coronary intervention (PPCI). MATERIALS AND METHODS: Fifty STEMI patients were prospectively recruited between August 2013 and July 2014 following informed consent. Forty-eight patients completed a 1.5T cardiac magnetic resonance imaging (MRI) with native T(1) , T(2) , and T2* maps at 4 ± 2 days. Receiver operating characteristic (ROC) analyses were performed to assess the performance of T(1) and T(2) to detect IMH. RESULTS: The mean age was 59 ± 13 years old and 88% (24/48) were male. In all, 39 patients had interpretable T2* maps and 26/39 (67%) of the patients had IMH ( T2* <20 msec on T2* maps). Both T(1) and T(2) values of the hypointense core within the area-at-risk (AAR) performed equally well to detect IMH (T(1) maps AUC 0.86 [95% confidence interval [CI] 0.72-0.99] versus T(2) maps AUC 0.86 [95% CI 0.74-0.99]; P = 0.94). Using the binary assessment of presence or absence of a hypointense core on the maps, the diagnostic performance of T(1) and T(2) remained equally good (T(1) AUC 0.87 [95% CI 0.73-1.00] versus T(2) AUC 0.85 [95% CI 0.71-0.99]; P = 0.90) with good sensitivity and specificity (T(1) : 88% and 85% and T(2) : 85% and 85%, respectively). CONCLUSION: The presence of a hypointense core on the T(1) and T(2) maps can detect IMH equally well and with good sensitivity and specificity in reperfused STEMI patients and could be used as an alternative when T2* images are not acquired or are not interpretable. LEVEL OF EVIDENCE: 2 Technical Efficacy: Stage 2 J. MAGN. RESON. IMAGING 2017;46:877-886.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。